NCT01283997 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Participants received a placebo of one dose on the first day of induction therapy for multiple myeloma, then doses every 12 hours for 10 weeks.
- id
- FG000
- title
- Placebo Group
- description
- Participants received minocycline 200 mg orally for 1 dose, then 100 mg orally every 12 hours for 10 weeks beginning at initiation of induction therapy for multiple myeloma
- id
- FG001
- title
- Minocycline Group
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 8
- group Id
- FG001
- num Subjects
- 10
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- type
- Physically unable to continue
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- type
- Progressive disease
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 4
- type
- Other
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 39
- group Id
- FG001
- num Subjects
- 40
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 23
- group Id
- FG001
- num Subjects
- 23
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 16
- group Id
- FG001
- num Subjects
- 17
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- 79 Participants signed consent
Complete source fields
- groups
- description
- Participants received a placebo of one dose on the first day of induction therapy for multiple myeloma, then doses every 12 hours for 10 weeks.
- id
- FG000
- title
- Placebo Group
- description
- Participants received minocycline 200 mg orally for 1 dose, then 100 mg orally every 12 hours for 10 weeks beginning at initiation of induction therapy for multiple myeloma
- id
- FG001
- title
- Minocycline Group
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 8
- group Id
- FG001
- num Subjects
- 10
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- type
- Physically unable to continue
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- type
- Progressive disease
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 4
- type
- Other
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 39
- group Id
- FG001
- num Subjects
- 40
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 23
- group Id
- FG001
- num Subjects
- 23
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 16
- group Id
- FG001
- num Subjects
- 17
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- 79 Participants signed consent
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle